DrugInfoSys

Ketotifen (Fumarate)

Drug #411

Ketotifen (Fumarate) is potent antihistaminic agent which exhibit strong H1 receptor blocking activity. Ketotifen (Fumarate) is prepared synthetically. Ketotifen (Fumarate) is effective in the preventive management for asthma and in the treatment of allergic conditions such as rhinitis and conjunctivitis. Ketotifen (Fumarate) is administered orally.

Primary Characteristics

It is of Synthetic origin and belongs to Piperidylbenzocycloheptane.

It belongs to H1-antagonist pharmacological group on the basis of mechanism of action and also classified in Antihistamine, H1 Blocker, Opthalmic pharmacological group.

Molecular Weight: 425.5 · pKa: 8.43 · Solubility in Water: sparingaly soluble · Solubility in Alcohol: soluble · Non-proprietary name: Ketotifen (Fumarate).

Molecular structure of Ketotifen (Fumarate)

Pharmacokinetics

Absorption: Ketotifen (Fumarate) has an oral bioavailability is 50%.

Distribution: Ketotifen (Fumarate) has a plasma protein binding is >75%.

Elimination: it is metabolised via Hepatic (extensively), plasma half-life is 21 hr, renal excretion is 40%.

Advertisement

Indications

Ketotifen (Fumarate) is primarily indicated in conditions like Allergic conjunctivitis, Allergic rhinitis, Prophylaxis of asthma.

Ketotifen (Fumarate) is also indicated for secondary conditions like Dysfunctional uterine bleeding, menorrhagia.

Contraindications

Ketotifen (Fumarate) is contraindicated in conditions like Impaired alertness, Hypersensitivity.

Dosage

Ketotifen (Fumarate)'s dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
0.025 %0.025 %Every 12hOpthalmicWith food.
1.5 mg1.5 mgEvery 12hPO
Paediatric Dosage (20kg)
0.025 %0.025 %OpthalmicFrom 3 year of age.
500 ug500 ugEvery 12hOralRecommended in Paeds over 2 Years of Age
Neonatal Dosage (3kg)
0 – 0Not recommended in this age group

Drug Interactions

Unknown1 interaction

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

The signs and symptoms that are produced after acute overdosage of Ketotifen (Fumarate) are Bradycardia, Tachycardia , Convulsions , Drowsiness, Drowsiness, Confusion , Hyperactive reflexes, Cyanosis, Hyperexcitability , Dyspnea.

Ketotifen (Fumarate) is known to cause more or less tolerable side effects which are usually transient. These include Dizziness, Drowsiness, Dry mouth, Lethargy, Weight gain.

Warnings / Precautions

Ketotifen is limited for topical ophthalmic use only. Not to treat contact lens-related irritation. After ketotifen use, soft contact lense wearers should wait atleast 10 minutes before putting their lenses in. Do not wear contact lenses if eyes are red. Do not contaminate dropper tip or solution when placing drops in eyes. Safety and efficacy not established in patients < 3 years of age. Ketotifen should not be used in the treatment of acute asthma attack. It should not be used for the treatment of acute asthma attacks.

Interference in Pathology

Ketotifen (Fumarate) may interfere in the diagnosis of Elevated liver enzymes.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Storage Conditions

Ketotifen (Fumarate) should be stored Tab, Caps, Elixir, Eye Drops.

Drug Classification

  1. 1.25.1.1Oral/Parenteral antiasthmatics

Manufacturers